Phosphodiesterase 3 Inhibitor [EPC]

Phosphodiesterase 3 Inhibitor [EPC] was reported 6228 times

Drugs of the Phosphodiesterase 3 Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CARDIAC VEIN PERFORATION 5 0.5000
1 ACCELERATED IDIOVENTRICULAR RHYTHM 13 0.0878
2 CEREBRAL HYPERPERFUSION SYNDROME 7 0.0769
3 THERAPEUTIC DRUG MONITORING ANALYSIS INCORRECTLY PERFORMED 7 0.0737
4 ACINETOBACTER TEST POSITIVE 8 0.0412
5 BRONCHOSPASM PARADOXICAL 12 0.0399
6 CORONARY REVASCULARISATION 6 0.0380
7 NIKOLSKY'S SIGN 6 0.0331
8 ARTERIAL INSUFFICIENCY 6 0.0324
9 THROMBOTIC CEREBRAL INFARCTION 10 0.0265
10 ILIAC ARTERY OCCLUSION 7 0.0255
11 ENTEROBACTER TEST POSITIVE 6 0.0244
12 ABSENCE OF IMMEDIATE TREATMENT RESPONSE 5 0.0211
13 PUTAMEN HAEMORRHAGE 6 0.0211
14 HAEMOBILIA 7 0.0169
15 FEMORAL ARTERY OCCLUSION 5 0.0158
16 PERIPHERAL ARTERY OCCLUSION 22 0.0156
17 INTERMITTENT CLAUDICATION 20 0.0126
18 PERIPHERAL ARTERY STENOSIS 6 0.0125
19 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 49 0.0120
20 THALAMUS HAEMORRHAGE 9 0.0103
21 ARTERIOVENOUS FISTULA 5 0.0102
22 PRODUCT DEPOSIT 15 0.0096
23 ARTERIAL INJURY 7 0.0094
24 MULTIPLE DRUG THERAPY 7 0.0093
25 LACUNAR INFARCTION 21 0.0088
26 CORONARY ARTERY RESTENOSIS 5 0.0084
27 INCREASED VISCOSITY OF BRONCHIAL SECRETION 5 0.0078
28 BRAIN STEM HAEMORRHAGE 7 0.0074
29 PERIPHERAL ARTERY THROMBOSIS 10 0.0071
30 VASCULAR STENT THROMBOSIS 14 0.0069
31 PERIPHERAL VASCULAR DISORDER 35 0.0068
32 HYPERPARATHYROIDISM SECONDARY 17 0.0068
33 CEREBRAL VASOCONSTRICTION 5 0.0068
34 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 7 0.0066
35 SPUTUM INCREASED 14 0.0065
36 THROMBOSIS IN DEVICE 21 0.0064
37 CEREBELLAR HAEMORRHAGE 9 0.0063
38 LYMPHOCYTE STIMULATION TEST POSITIVE 5 0.0062
39 EXCESSIVE GRANULATION TISSUE 5 0.0062
40 EXTRADURAL HAEMATOMA 8 0.0060
41 NEPHROGENIC ANAEMIA 28 0.0060
42 DIVERTICULUM INTESTINAL HAEMORRHAGIC 13 0.0058
43 FOOT AMPUTATION 8 0.0055
44 CHOREA 9 0.0052
45 SICK SINUS SYNDROME 6 0.0052
46 RENAL HAEMORRHAGE 10 0.0049
47 BRAIN STEM INFARCTION 5 0.0049
48 CEREBRAL INFARCTION 118 0.0048
49 ASTERIXIS 5 0.0047
50 SUBCUTANEOUS HAEMATOMA 6 0.0047
51 OXYGEN CONSUMPTION INCREASED 11 0.0046
52 PRODUCT COLOUR ISSUE 23 0.0045
53 SMALL INTESTINAL HAEMORRHAGE 9 0.0045
54 KOUNIS SYNDROME 10 0.0044
55 SINUS NODE DYSFUNCTION 8 0.0044
56 VASCULAR OCCLUSION 9 0.0043
57 HAEMORRHAGE SUBCUTANEOUS 15 0.0042
58 LONG QT SYNDROME 10 0.0042
59 CARDIAC DEATH 5 0.0041
60 CEREBRAL ARTERY EMBOLISM 5 0.0041
61 AMPUTATION 5 0.0040
62 REBOUND ACID HYPERSECRETION 12 0.0040
63 PRODUCT SOLUBILITY ABNORMAL 20 0.0040
64 MARASMUS 6 0.0039
65 CAROTID ARTERY DISEASE 5 0.0039
66 PERIPHERAL ISCHAEMIA 16 0.0039
67 PANCREATITIS NECROTISING 9 0.0039
68 CAROTID ARTERY OCCLUSION 14 0.0038
69 SINUS ARREST 6 0.0038
70 ESSENTIAL HYPERTENSION 7 0.0038
71 INTESTINAL ISCHAEMIA 21 0.0038
72 STAPHYLOCOCCUS TEST POSITIVE 8 0.0038
73 VENTRICULAR FIBRILLATION 42 0.0038
74 POOR PERIPHERAL CIRCULATION 16 0.0038
75 ARTERIAL THROMBOSIS 7 0.0036
76 GASTRIC ULCER HAEMORRHAGE 20 0.0036
77 CAROTID ARTERY STENOSIS 12 0.0034
78 WOUND SECRETION 13 0.0033
79 GANGRENE 20 0.0033
80 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 173 0.0033
81 VENOUS OCCLUSION 6 0.0033
82 BRAIN NATRIURETIC PEPTIDE INCREASED 10 0.0032
83 LOBAR PNEUMONIA 6 0.0032
84 MUSCLE HAEMORRHAGE 13 0.0032
85 ANGIOPATHY 18 0.0032
86 PERICARDIAL HAEMORRHAGE 7 0.0032
87 CORONARY ARTERY STENOSIS 16 0.0032
88 PEMPHIGOID 24 0.0032
89 LIQUID PRODUCT PHYSICAL ISSUE 23 0.0032
90 ARTERIAL DISORDER 6 0.0031
91 FIBRIN D DIMER INCREASED 11 0.0031
92 TORSADE DE POINTES 24 0.0031
93 INTESTINAL POLYP 5 0.0030
94 BRAIN HERNIATION 9 0.0030
95 INGROWING NAIL 7 0.0030
96 DIABETIC FOOT 9 0.0029
97 EXTREMITY NECROSIS 5 0.0029
98 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 25 0.0028
99 PNEUMATOSIS INTESTINALIS 8 0.0028
100 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 14 0.0028
101 HAEMOTHORAX 8 0.0028
102 CARDIAC TAMPONADE 13 0.0027
103 VENTRICULAR ARRHYTHMIA 10 0.0027
104 PROTHROMBIN TIME PROLONGED 16 0.0027
105 BLADDER SPASM 5 0.0027
106 SUPRAVENTRICULAR EXTRASYSTOLES 9 0.0027
107 GASTRIC POLYPS 6 0.0027
108 END STAGE RENAL DISEASE 48 0.0026
109 LEFT VENTRICULAR FAILURE 9 0.0026
110 PRODUCT PREPARATION ISSUE 17 0.0026
111 ABDOMINAL WALL HAEMATOMA 5 0.0026
112 OCCULT BLOOD POSITIVE 5 0.0025
113 HAEMORRHAGIC ANAEMIA 11 0.0025
114 PULMONARY ALVEOLAR HAEMORRHAGE 14 0.0025
115 ANGINA UNSTABLE 16 0.0025
116 BRONCHOSPASM 35 0.0025
117 OSTEOLYSIS 5 0.0024
118 LEG AMPUTATION 10 0.0024
119 VENTRICULAR TACHYCARDIA 40 0.0024
120 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 8 0.0024
121 AORTIC DISSECTION 10 0.0024
122 INTRAVENTRICULAR HAEMORRHAGE 6 0.0024
123 CEREBRAL HAEMATOMA 8 0.0024
124 CARDIAC FAILURE CHRONIC 10 0.0023
125 REHABILITATION THERAPY 9 0.0023
126 UPPER GASTROINTESTINAL HAEMORRHAGE 39 0.0023
127 HEMIPLEGIA 19 0.0023
128 SUBDURAL HAEMATOMA 32 0.0022
129 SPRUE-LIKE ENTEROPATHY 11 0.0022
130 VENTRICULAR EXTRASYSTOLES 23 0.0022
131 LARGE INTESTINAL ULCER 6 0.0022
132 BLOOD LOSS ANAEMIA 5 0.0022
133 VITREOUS HAEMORRHAGE 6 0.0022
134 NECROSIS 12 0.0022
135 SUDDEN CARDIAC DEATH 7 0.0021
136 WOUND COMPLICATION 7 0.0020
137 LOWER GASTROINTESTINAL HAEMORRHAGE 15 0.0020
138 THORACIC VERTEBRAL FRACTURE 6 0.0020
139 CREPITATIONS 6 0.0020
140 INTRACRANIAL ANEURYSM 8 0.0020
141 INTERNATIONAL NORMALISED RATIO DECREASED 8 0.0020
142 TOE AMPUTATION 10 0.0020
143 HAEMORRHAGIC DIATHESIS 7 0.0020
144 LUMBAR VERTEBRAL FRACTURE 9 0.0020
145 SUBARACHNOID HAEMORRHAGE 20 0.0020
146 CARDIAC FAILURE ACUTE 13 0.0019
147 AORTIC ARTERIOSCLEROSIS 5 0.0019
148 BENIGN PROSTATIC HYPERPLASIA 10 0.0019
149 SKIN NECROSIS 10 0.0019
150 MELAENA 42 0.0019
151 CHRONIC KIDNEY DISEASE 144 0.0019
152 POLYMYALGIA RHEUMATICA 6 0.0019
153 EMPHYSEMA 19 0.0019
154 PNEUMONIA ASPIRATION 47 0.0019
155 CARDIAC DYSFUNCTION 7 0.0019
156 LEFT VENTRICULAR HYPERTROPHY 8 0.0019
157 ABDOMINAL MASS 5 0.0019
158 COMPRESSION FRACTURE 10 0.0019
159 PORTAL VEIN THROMBOSIS 6 0.0019
160 BLOOD UREA INCREASED 31 0.0018
161 HEPATIC FUNCTION ABNORMAL 69 0.0018
162 DISSEMINATED INTRAVASCULAR COAGULATION 26 0.0018
163 DIVERTICULUM INTESTINAL 8 0.0018
164 HEPARIN-INDUCED THROMBOCYTOPENIA 9 0.0018
165 GASTRIC HAEMORRHAGE 21 0.0018
166 DIABETIC NEUROPATHY 9 0.0018
167 ARTERIOSCLEROSIS CORONARY ARTERY 12 0.0018
168 ARTERIOSCLEROSIS 17 0.0018
169 CHOLECYSTITIS INFECTIVE 5 0.0018
170 HEART RATE ABNORMAL 10 0.0018
171 ARTERIAL OCCLUSIVE DISEASE 14 0.0018
172 ACUTE MYOCARDIAL INFARCTION 52 0.0018
173 GRANULOCYTOPENIA 10 0.0018
174 AZOTAEMIA 7 0.0018
175 APLASIA PURE RED CELL 6 0.0017
176 DIFFICULTY IN WALKING 6 0.0017
177 SHOCK HAEMORRHAGIC 14 0.0017
178 GASTROINTESTINAL NECROSIS 5 0.0017
179 SPINAL COMPRESSION FRACTURE 14 0.0017
180 HAEMOPTYSIS 47 0.0017
181 INTERSTITIAL LUNG DISEASE 81 0.0017
182 PULMONARY CONGESTION 22 0.0017
183 SCLERODERMA 6 0.0016
184 ATRIOVENTRICULAR BLOCK SECOND DEGREE 5 0.0016
185 CEREBRAL HAEMORRHAGE 59 0.0016
186 INTENTIONAL UNDERDOSE 12 0.0016
187 PRODUCT PHYSICAL CONSISTENCY ISSUE 9 0.0016
188 HYPERVOLAEMIA 8 0.0016
189 HYPERTENSIVE CRISIS 18 0.0016
190 ATRIOVENTRICULAR BLOCK FIRST DEGREE 7 0.0016
191 MONOPLEGIA 7 0.0016
192 OLIGURIA 10 0.0016
193 GASTROINTESTINAL HAEMORRHAGE 134 0.0016
194 BLOOD BLISTER 5 0.0016
195 DERMATITIS EXFOLIATIVE 8 0.0016
196 RESPIRATION ABNORMAL 11 0.0016
197 SPINAL OSTEOARTHRITIS 14 0.0016
198 PRODUCT STORAGE ISSUE 6 0.0016
199 AORTIC ANEURYSM 12 0.0016
200 RHINITIS ALLERGIC 7 0.0016
201 ORTHOPNOEA 5 0.0016
202 ALTERED STATE OF CONSCIOUSNESS 34 0.0016
203 CEREBRAL ISCHAEMIA 8 0.0016
204 CARDIOMEGALY 19 0.0015
205 BLOOD PRESSURE SYSTOLIC DECREASED 7 0.0015
206 HYPOVOLAEMIA 9 0.0015
207 CORONARY ARTERY OCCLUSION 21 0.0015
208 PROSTATOMEGALY 6 0.0015
209 ISCHAEMIA 7 0.0015
210 HAEMATOMA 39 0.0015
211 CARDIAC MURMUR 13 0.0015
212 NEPHRITIS 5 0.0015
213 MIOSIS 12 0.0015
214 PSYCHIATRIC SYMPTOM 11 0.0015
215 DRUG EFFECT LESS THAN EXPECTED 22 0.0015
216 BRONCHIECTASIS 10 0.0015
217 SHOCK 34 0.0015
218 HEPATIC CYST 5 0.0015
219 DIABETIC RETINOPATHY 5 0.0015
220 INFARCTION 10 0.0015
221 POST PROCEDURAL HAEMORRHAGE 17 0.0015
222 CERVICAL VERTEBRAL FRACTURE 5 0.0014
223 TUBULOINTERSTITIAL NEPHRITIS 27 0.0014
224 RENAL FAILURE CHRONIC 11 0.0014
225 PRODUCTIVE COUGH 68 0.0014
226 POOR QUALITY PRODUCT ADMINISTERED 15 0.0014
227 PNEUMONIA BACTERIAL 13 0.0014
228 TONGUE DISCOMFORT 6 0.0014
229 INTERVERTEBRAL DISC DISORDER 6 0.0014
230 RETINAL HAEMORRHAGE 10 0.0014
231 ACUTE RESPIRATORY FAILURE 27 0.0014
232 TRANSIENT ISCHAEMIC ATTACK 47 0.0014
233 PHOTOSENSITIVITY REACTION 23 0.0014
234 RENAL CYST 11 0.0014
235 PYELONEPHRITIS 12 0.0014
236 FEMORAL NECK FRACTURE 7 0.0014
237 SECRETION DISCHARGE 17 0.0014
238 SKIN ULCER 35 0.0014
239 BLOOD PRESSURE INADEQUATELY CONTROLLED 8 0.0013
240 ANGINA PECTORIS 38 0.0013
241 MITRAL VALVE INCOMPETENCE 15 0.0013
242 HYPERGLYCAEMIA 48 0.0013
243 FACE INJURY 5 0.0013
244 BUNDLE BRANCH BLOCK RIGHT 6 0.0013
245 UROSEPSIS 12 0.0013
246 OESOPHAGEAL DISORDER 5 0.0013
247 PRODUCT RESIDUE PRESENT 7 0.0013
248 CHOLANGITIS 8 0.0013
249 GASTRITIS EROSIVE 6 0.0013
250 PELVIC FRACTURE 10 0.0013
251 CARDIAC FAILURE 103 0.0013
252 SKIN TIGHTNESS 6 0.0013
253 OSTEOMYELITIS 23 0.0013
254 HYPERKERATOSIS 7 0.0013
255 ATRIAL FIBRILLATION 123 0.0013
256 PNEUMOTHORAX 20 0.0013
257 CEREBRAL ATROPHY 5 0.0013
258 CREATININE RENAL CLEARANCE DECREASED 5 0.0012
259 FAECAL INCONTINENCE 6 0.0012
260 BLOOD ALKALINE PHOSPHATASE INCREASED 31 0.0012
261 DIABETES MELLITUS INADEQUATE CONTROL 22 0.0012
262 STENT PLACEMENT 10 0.0012
263 RESPIRATORY RATE INCREASED 11 0.0012
264 DIZZINESS POSTURAL 12 0.0012
265 HYPOGLYCAEMIA 60 0.0012
266 MOUTH HAEMORRHAGE 9 0.0012
267 DECUBITUS ULCER 10 0.0012
268 ENTEROCOLITIS 7 0.0012
269 RENAL FAILURE 160 0.0012
270 HYPERNATRAEMIA 6 0.0012
271 BLOOD PRESSURE DECREASED 80 0.0012
272 STRESS CARDIOMYOPATHY 7 0.0012
273 EOSINOPHIL COUNT INCREASED 10 0.0012
274 VEIN DISORDER 6 0.0012
275 SINUS TACHYCARDIA 17 0.0012
276 IRON DEFICIENCY ANAEMIA 11 0.0012
277 CORONARY ARTERY DISEASE 36 0.0012
278 PRODUCT DISTRIBUTION ISSUE 11 0.0012
279 TOXIC EPIDERMAL NECROLYSIS 18 0.0012
280 PATHOLOGICAL FRACTURE 6 0.0012
281 PRODUCT LABEL ISSUE 8 0.0012
282 RENAL IMPAIRMENT 99 0.0012
283 CARDIAC FAILURE CONGESTIVE 94 0.0012
284 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 12 0.0012
285 MALNUTRITION 13 0.0012
286 SPUTUM DISCOLOURED 11 0.0012
287 MULTI-ORGAN FAILURE 20 0.0012
288 EXTRASYSTOLES 8 0.0011
289 HAEMATURIA 39 0.0011
290 CONCOMITANT DISEASE AGGRAVATED 7 0.0011
291 ILEUS PARALYTIC 5 0.0011
292 ELECTROLYTE IMBALANCE 13 0.0011
293 PARALYSIS 16 0.0011
294 DYSPNOEA EXERTIONAL 42 0.0011
295 GASTRIC ULCER 21 0.0011
296 LIMB INJURY 30 0.0011
297 CARDIO-RESPIRATORY ARREST 46 0.0011
298 ASPIRATION 12 0.0011
299 UPPER-AIRWAY COUGH SYNDROME 9 0.0011
300 ANOREXIA 14 0.0011
301 BLOOD CHOLESTEROL ABNORMAL 5 0.0011
302 LOCALISED INFECTION 26 0.0011
303 CHEST DISCOMFORT 110 0.0011
304 PULMONARY MASS 16 0.0011
305 DRUG ERUPTION 19 0.0011
306 HAEMORRHAGE INTRACRANIAL 16 0.0011
307 POLYP 7 0.0011
308 DIALYSIS 15 0.0011
309 COLITIS MICROSCOPIC 5 0.0011
310 GENERALISED ERYTHEMA 6 0.0011
311 RHABDOMYOLYSIS 44 0.0011
312 ANAEMIA 201 0.0011
313 DYSPNOEA 595 0.0011
314 CARDIAC VALVE DISEASE 6 0.0010
315 BLOOD POTASSIUM INCREASED 17 0.0010
316 HYPOVOLAEMIC SHOCK 5 0.0010
317 DRUG INTERACTION 165 0.0010
318 SUDDEN DEATH 11 0.0010
319 PULMONARY HAEMORRHAGE 8 0.0010
320 PNEUMONIA 330 0.0010
321 CARDIOMYOPATHY 15 0.0010
322 LIVER DISORDER 45 0.0010
323 BREATH SOUNDS ABNORMAL 5 0.0010
324 ARRHYTHMIA 48 0.0010
325 MYDRIASIS 13 0.0010
326 SEPTIC SHOCK 44 0.0010
327 LARGE INTESTINE POLYP 7 0.0010
328 BLOOD ALBUMIN DECREASED 8 0.0010
329 FACIAL PAIN 9 0.0010
330 GASTROINTESTINAL INFECTION 9 0.0010
331 BLOOD URINE PRESENT 19 0.0010
332 HYPERKALAEMIA 35 0.0010
333 ACUTE KIDNEY INJURY 152 0.0010
334 TACHYCARDIA 88 0.0010
335 PULMONARY TOXICITY 7 0.0010
336 ADRENAL INSUFFICIENCY 12 0.0010
337 CORONARY ARTERIAL STENT INSERTION 5 0.0010
338 HAEMATEMESIS 25 0.0010
339 PLEURAL EFFUSION 60 0.0010
340 ASPARTATE AMINOTRANSFERASE INCREASED 52 0.0010
341 OXYGEN SATURATION DECREASED 55 0.0010
342 RENAL INJURY 29 0.0010
343 LARYNGEAL OEDEMA 6 0.0010
344 PIGMENTATION DISORDER 6 0.0010
345 GENERALISED OEDEMA 12 0.0010
346 MYOCARDIAL ISCHAEMIA 11 0.0010
347 ACUTE CORONARY SYNDROME 8 0.0010
348 FLANK PAIN 9 0.0010
349 RESPIRATORY TRACT INFECTION 25 0.0010
350 ISCHAEMIC STROKE 17 0.0010
351 ELECTROCARDIOGRAM QT PROLONGED 34 0.0009
352 RENAL DISORDER 44 0.0009
353 IMPAIRED HEALING 31 0.0009
354 HYPOPHAGIA 24 0.0009
355 PULMONARY OEDEMA 42 0.0009
356 OVERWEIGHT 5 0.0009
357 HIATUS HERNIA 12 0.0009
358 RENAL FAILURE ACUTE 39 0.0009
359 BEDRIDDEN 12 0.0009
360 FAECALOMA 5 0.0009
361 INTERNATIONAL NORMALISED RATIO INCREASED 26 0.0009
362 HOSPICE CARE 9 0.0009
363 GROIN PAIN 8 0.0009
364 PURPURA 8 0.0009
365 GAMMA-GLUTAMYLTRANSFERASE INCREASED 20 0.0009
366 HYPOALBUMINAEMIA 7 0.0009
367 COAGULOPATHY 15 0.0009
368 WRONG DRUG ADMINISTERED 8 0.0009
369 PULMONARY ARTERIAL HYPERTENSION 13 0.0009
370 GLOMERULAR FILTRATION RATE DECREASED 11 0.0009
371 FLUID OVERLOAD 13 0.0009
372 ACUTE PULMONARY OEDEMA 5 0.0009
373 ANAL INCONTINENCE 8 0.0009
374 PRODUCT DOSE OMISSION IN ERROR 25 0.0009
375 TRICUSPID VALVE INCOMPETENCE 7 0.0009
376 HYPOXIA 31 0.0009
377 ATRIAL FLUTTER 7 0.0009
378 THERAPY CESSATION 45 0.0009
379 INTERNAL HAEMORRHAGE 10 0.0009
380 RIB FRACTURE 18 0.0009
381 BLOOD PRESSURE FLUCTUATION 21 0.0009
382 ALANINE AMINOTRANSFERASE INCREASED 53 0.0009
383 HYPERVENTILATION 5 0.0009
384 ECONOMIC PROBLEM 13 0.0009
385 ERYTHEMA MULTIFORME 8 0.0009
386 OSTEOPENIA 13 0.0009
387 SPINAL PAIN 10 0.0009
388 C-REACTIVE PROTEIN INCREASED 31 0.0009
389 INSURANCE ISSUE 13 0.0008
390 OEDEMA 46 0.0008
391 DECREASED INTEREST 5 0.0008
392 HAEMOGLOBIN DECREASED 87 0.0008
393 DIVERTICULUM 6 0.0008
394 PRODUCT PHYSICAL ISSUE 17 0.0008
395 CATARACT OPERATION 5 0.0008
396 CHOLECYSTITIS 10 0.0008
397 CARDIAC PACEMAKER INSERTION 5 0.0008
398 HYPERLIPIDAEMIA 10 0.0008
399 CARDIOGENIC SHOCK 12 0.0008
400 DECREASED ACTIVITY 9 0.0008
401 HAEMODIALYSIS 7 0.0008
402 CELLULITIS 42 0.0008
403 POST PROCEDURAL COMPLICATION 16 0.0008
404 PANIC REACTION 6 0.0008
405 FAECES DISCOLOURED 18 0.0008
406 HYPERCHOLESTEROLAEMIA 8 0.0008
407 ATELECTASIS 8 0.0008
408 HYPOKINESIA 12 0.0008
409 INTERVERTEBRAL DISC PROTRUSION 18 0.0008
410 FALL 274 0.0008
411 PERICARDIAL EFFUSION 19 0.0008
412 PERITONITIS 17 0.0008
413 BLOOD LACTATE DEHYDROGENASE INCREASED 13 0.0008
414 RESPIRATORY TRACT CONGESTION 13 0.0008
415 DEHYDRATION 109 0.0008
416 PRODUCT CONTAINER ISSUE 7 0.0008
417 PSEUDOMONAS INFECTION 7 0.0008
418 BLOOD BILIRUBIN INCREASED 22 0.0008
419 BACTERIAL INFECTION 15 0.0008
420 PERIPHERAL COLDNESS 11 0.0008
421 BLOOD CREATINE PHOSPHOKINASE INCREASED 23 0.0008
422 HAEMATOCHEZIA 44 0.0008
423 WOUND 22 0.0008
424 HYPOKALAEMIA 36 0.0008
425 BACK PAIN 180 0.0008
426 EJECTION FRACTION DECREASED 12 0.0008
427 OEDEMA PERIPHERAL 94 0.0008
428 HAEMORRHAGIC STROKE 6 0.0008
429 PULMONARY HYPERTENSION 16 0.0008
430 URINARY TRACT INFECTION 131 0.0008
431 TENDERNESS 8 0.0008
432 PLATELET COUNT INCREASED 10 0.0008
433 RASH MACULO-PAPULAR 17 0.0008
434 TRANSFUSION 8 0.0008
435 DYSURIA 28 0.0008
436 BACTERAEMIA 9 0.0008
437 NASAL DISCOMFORT 6 0.0008
438 HAEMATOCRIT DECREASED 15 0.0008
439 PANCREATITIS ACUTE 17 0.0008
440 BLOOD PRESSURE ABNORMAL 15 0.0008
441 DEMENTIA 21 0.0008
442 CARDIAC ARREST 62 0.0008
443 HYPERTENSION 159 0.0007
444 DELIRIUM 26 0.0007
445 HIP FRACTURE 24 0.0007
446 SQUAMOUS CELL CARCINOMA 7 0.0007
447 MYASTHENIA GRAVIS 6 0.0007
448 CATARACT 44 0.0007
449 COLON CANCER 11 0.0007
450 PRODUCT PACKAGING ISSUE 7 0.0007
451 SKIN LACERATION 8 0.0007
452 ASPHYXIA 6 0.0007
453 RED BLOOD CELL COUNT DECREASED 21 0.0007
454 ABNORMAL FAECES 6 0.0007
455 BLOOD GLUCOSE FLUCTUATION 8 0.0007
456 ESCHERICHIA INFECTION 6 0.0007
457 ECCHYMOSIS 5 0.0007
458 HEAD INJURY 23 0.0007
459 PROSTATIC SPECIFIC ANTIGEN INCREASED 10 0.0007
460 PALPITATIONS 85 0.0007
461 WHEEZING 43 0.0007
462 DRUG LEVEL INCREASED 12 0.0007
463 SINUS BRADYCARDIA 7 0.0007
464 URINARY RETENTION 24 0.0007
465 GAIT INABILITY 24 0.0007
466 CHEST PAIN 133 0.0007
467 LOSS OF CONSCIOUSNESS 92 0.0007
468 CARPAL TUNNEL SYNDROME 10 0.0007
469 BONE DISORDER 13 0.0007
470 DECREASED APPETITE 165 0.0007
471 INABILITY TO AFFORD MEDICATION 7 0.0007
472 PRODUCT USE COMPLAINT 11 0.0007
473 HYPOTENSION 140 0.0007
474 DIABETES MELLITUS 53 0.0007
475 TOXIC SKIN ERUPTION 7 0.0007
476 EXPOSURE VIA SKIN CONTACT 18 0.0007
477 CYSTITIS 22 0.0007
478 BLOOD CREATININE INCREASED 45 0.0007
479 DRY THROAT 7 0.0007
480 FAECES SOFT 5 0.0007
481 DIVERTICULITIS 19 0.0007
482 RESPIRATORY FAILURE 50 0.0007
483 THROMBOSIS 55 0.0007
484 DEPRESSED LEVEL OF CONSCIOUSNESS 27 0.0007
485 FEELING JITTERY 13 0.0007
486 OSTEOPOROSIS 28 0.0007
487 GLAUCOMA 13 0.0007
488 DIARRHOEA 433 0.0007
489 MYOCLONUS 8 0.0007
490 MYOCARDIAL INFARCTION 117 0.0007
491 COUGH 188 0.0007
492 MYOSITIS 6 0.0007
493 HEART RATE INCREASED 66 0.0007
494 OROPHARYNGEAL DISCOMFORT 6 0.0007
495 HEART RATE IRREGULAR 15 0.0007
496 APHASIA 20 0.0007
497 NECK PAIN 37 0.0007
498 PAIN IN EXTREMITY 195 0.0007
499 BRADYCARDIA 35 0.0007
500 NOCTURIA 8 0.0007
501 ABNORMAL BEHAVIOUR 26 0.0007
502 BODY HEIGHT DECREASED 7 0.0007
503 ACIDOSIS 5 0.0007
504 ABNORMAL DREAMS 18 0.0007
505 PRESCRIBED UNDERDOSE 13 0.0007
506 HEMIPARESIS 11 0.0006
507 BLOOD PRESSURE INCREASED 99 0.0006
508 ATRIOVENTRICULAR BLOCK 5 0.0006
509 TENDONITIS 10 0.0006
510 FULL BLOOD COUNT DECREASED 13 0.0006
511 ILEUS 8 0.0006
512 LUNG INFECTION 10 0.0006
513 DEFORMITY 6 0.0006
514 OESOPHAGITIS 7 0.0006
515 HYPONATRAEMIA 36 0.0006
516 CYANOSIS 10 0.0006
517 GLYCOSYLATED HAEMOGLOBIN INCREASED 16 0.0006
518 SPINAL DISORDER 6 0.0006
519 BRAIN OEDEMA 8 0.0006
520 JAUNDICE 17 0.0006
521 MUSCLE ATROPHY 8 0.0006
522 CARDIOVASCULAR DISORDER 16 0.0006
523 STEVENS-JOHNSON SYNDROME 14 0.0006
524 FLUID RETENTION 32 0.0006
525 ULCER 10 0.0006
526 CONTRAINDICATED PRODUCT ADMINISTERED 19 0.0006
527 PANCYTOPENIA 35 0.0006
528 PNEUMONITIS 17 0.0006
529 SEPSIS 69 0.0006
530 ASTHENIA 232 0.0006
531 PRESYNCOPE 15 0.0006
532 GASTROENTERITIS 9 0.0006
533 CHOKING 12 0.0006
534 FEMUR FRACTURE 19 0.0006
535 GOUT 11 0.0006
536 NODULE 8 0.0006
537 CONTUSION 59 0.0006
538 AGITATION 45 0.0006
539 MYOCARDITIS 7 0.0006
540 EATING DISORDER 13 0.0006
541 CARDIAC DISORDER 57 0.0006
542 GASTRITIS 16 0.0006
543 LIGAMENT SPRAIN 6 0.0006
544 EMBOLISM 5 0.0006
545 RESPIRATORY DISORDER 18 0.0006
546 THERAPY INTERRUPTED 43 0.0006
547 SALIVARY HYPERSECRETION 6 0.0006
548 METABOLIC ACIDOSIS 19 0.0006
549 TYPE 2 DIABETES MELLITUS 20 0.0006
550 AGRANULOCYTOSIS 11 0.0006
551 LUNG DISORDER 29 0.0006
552 MOVEMENT DISORDER 19 0.0006
553 EYELID PTOSIS 6 0.0006
554 DYSPHAGIA 56 0.0006
555 OSTEOARTHRITIS 25 0.0006
556 TOOTH ABSCESS 6 0.0006
557 NEUTROPHIL COUNT DECREASED 24 0.0006
558 MOTOR DYSFUNCTION 6 0.0006
559 SLUGGISHNESS 6 0.0006
560 PALLOR 16 0.0006
561 WEIGHT DECREASED 164 0.0006
562 IMPAIRED GASTRIC EMPTYING 8 0.0006
563 DRUG ADMINISTRATION ERROR 18 0.0006
564 MACULAR DEGENERATION 7 0.0006
565 PHARYNGEAL OEDEMA 9 0.0006
566 TREATMENT NONCOMPLIANCE 32 0.0006
567 DYSARTHRIA 22 0.0006
568 CEREBROVASCULAR ACCIDENT 99 0.0006
569 BLOOD SODIUM DECREASED 11 0.0006
570 BLOOD GLUCOSE DECREASED 28 0.0006
571 RECTAL HAEMORRHAGE 25 0.0006
572 ANAPHYLACTIC SHOCK 15 0.0006
573 LIMB DISCOMFORT 18 0.0006
574 CARDIAC OPERATION 5 0.0006
575 ANKLE FRACTURE 9 0.0006
576 DISORIENTATION 23 0.0006
577 HOSPITALISATION 89 0.0006
578 MUSCLE STRAIN 5 0.0006
579 MENTAL IMPAIRMENT 14 0.0006
580 BASAL CELL CARCINOMA 9 0.0006
581 MENTAL STATUS CHANGES 16 0.0006
582 ORTHOSTATIC HYPOTENSION 10 0.0006
583 NERVOUSNESS 30 0.0006
584 HAEMORRHAGE 60 0.0006
585 DRUG-INDUCED LIVER INJURY 18 0.0006
586 HALLUCINATION 43 0.0006
587 SYNCOPE 57 0.0006
588 SKIN DISORDER 19 0.0006
589 SCRATCH 6 0.0006
590 HALLUCINATION, VISUAL 12 0.0006
591 ABASIA 14 0.0006
592 RENAL PAIN 6 0.0006
593 EAR PAIN 11 0.0006
594 LYMPHOPENIA 8 0.0006
595 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
596 SEASONAL ALLERGY 8 0.0006
597 BLOOD PRESSURE SYSTOLIC INCREASED 11 0.0006
598 HAEMORRHOIDS 11 0.0006
599 NO ADVERSE EVENT 102 0.0006
600 HEREDITARY ANGIOEDEMA 6 0.0006
601 MUSCULAR WEAKNESS 63 0.0006
602 GAIT DISTURBANCE 106 0.0006
603 MYELODYSPLASTIC SYNDROME 8 0.0006
604 GASTRIC CANCER 14 0.0006
605 PULMONARY THROMBOSIS 6 0.0005
606 SPINAL FRACTURE 11 0.0005
607 RESTLESSNESS 20 0.0005
608 TOOTH FRACTURE 6 0.0005
609 RESPIRATORY ARREST 15 0.0005
610 TASTE DISORDER 11 0.0005
611 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
612 PERIPHERAL SWELLING 83 0.0005
613 PRODUCT DOSE OMISSION ISSUE 158 0.0005
614 HYPERHIDROSIS 69 0.0005
615 NEPHROPATHY 5 0.0005
616 ARTHRITIS 42 0.0005
617 ANHEDONIA 14 0.0005
618 BLOOD POTASSIUM DECREASED 16 0.0005
619 MULTIPLE ORGAN DYSFUNCTION SYNDROME 15 0.0005
620 SCAB 6 0.0005
621 EYE HAEMORRHAGE 7 0.0005
622 VISION BLURRED 72 0.0005
623 NEPHROLITHIASIS 24 0.0005
624 INFLAMMATION 27 0.0005
625 SKIN DISCOLOURATION 24 0.0005
626 HERPES ZOSTER 30 0.0005
627 WHITE BLOOD CELL COUNT INCREASED 20 0.0005
628 CONSTIPATION 113 0.0005
629 THROAT TIGHTNESS 14 0.0005
630 MADAROSIS 6 0.0005
631 TACHYPNOEA 7 0.0005
632 BLOOD IRON DECREASED 6 0.0005
633 PRODUCT PRESCRIBING ISSUE 11 0.0005
634 ORAL DISCOMFORT 7 0.0005
635 BLADDER DISORDER 5 0.0005
636 HYPOMAGNESAEMIA 7 0.0005
637 APHONIA 7 0.0005
638 HYPOTHYROIDISM 16 0.0005
639 MASS 7 0.0005
640 LEUKOCYTOSIS 9 0.0005
641 DEEP VEIN THROMBOSIS 32 0.0005
642 DEPRESSED MOOD 26 0.0005
643 BLINDNESS 20 0.0005
644 BLOOD GLUCOSE INCREASED 92 0.0005
645 CHOLELITHIASIS 16 0.0005
646 PLATELET COUNT DECREASED 52 0.0005
647 INITIAL INSOMNIA 5 0.0005
648 CHROMATURIA 11 0.0005
649 EYE DISORDER 16 0.0005
650 HELICOBACTER INFECTION 5 0.0005
651 TENDON RUPTURE 6 0.0005
652 GASTROOESOPHAGEAL REFLUX DISEASE 39 0.0005
653 HEART RATE DECREASED 17 0.0005
654 TOOTH EXTRACTION 6 0.0005
655 APATHY 7 0.0005
656 POLLAKIURIA 20 0.0005
657 DYSSTASIA 14 0.0005
658 AMNESIA 31 0.0005
659 UPPER RESPIRATORY TRACT INFECTION 22 0.0005
660 CANDIDA INFECTION 8 0.0005
661 JOINT DISLOCATION 5 0.0005
662 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
663 RESPIRATORY DISTRESS 13 0.0005
664 CIRCULATORY COLLAPSE 8 0.0005
665 PULMONARY FIBROSIS 9 0.0005
666 RETCHING 10 0.0005
667 EPISTAXIS 35 0.0005
668 SCAR 8 0.0005
669 HERNIA 9 0.0005
670 MUSCULOSKELETAL DISCOMFORT 8 0.0005
671 ANXIETY 132 0.0005
672 DIZZINESS 231 0.0005
673 PRODUCT PRESCRIBING ERROR 11 0.0005
674 DEPRESSION 105 0.0005
675 BIPOLAR DISORDER 5 0.0005
676 PAIN IN JAW 13 0.0005
677 CONFUSIONAL STATE 74 0.0005
678 CONDITION AGGRAVATED 139 0.0005
679 TOOTH INFECTION 6 0.0005
680 WHITE BLOOD CELL COUNT DECREASED 49 0.0005
681 DENTAL CARIES 5 0.0005
682 UPPER LIMB FRACTURE 9 0.0005
683 INTESTINAL OBSTRUCTION 17 0.0005
684 RHINORRHOEA 29 0.0004
685 GALLBLADDER DISORDER 8 0.0004
686 INSOMNIA 119 0.0004
687 BRAIN FOG 7 0.0004
688 ORAL PAIN 10 0.0004
689 OCULAR DISCOMFORT 5 0.0004
690 PRODUCT ADMINISTRATION ERROR 9 0.0004
691 BLISTER 25 0.0004
692 BLOOD CALCIUM DECREASED 5 0.0004
693 BONE MARROW FAILURE 9 0.0004
694 HYPOAESTHESIA 66 0.0004
695 HALLUCINATION, AUDITORY 7 0.0004
696 BALANCE DISORDER 38 0.0004
697 GINGIVAL BLEEDING 6 0.0004
698 RASH ERYTHEMATOUS 21 0.0004
699 PRODUCT AVAILABILITY ISSUE 10 0.0004
700 SCIATICA 7 0.0004
701 URINARY INCONTINENCE 13 0.0004
702 PRODUCT PREPARATION ERROR 9 0.0004
703 CONVULSION 25 0.0004
704 SUICIDAL IDEATION 40 0.0004
705 SENSORY DISTURBANCE 7 0.0004
706 TREMOR 72 0.0004
707 BLOOD CHOLESTEROL INCREASED 20 0.0004
708 VOMITING 201 0.0004
709 MOUTH ULCERATION 9 0.0004
710 DEVICE OCCLUSION 6 0.0004
711 UNRESPONSIVE TO STIMULI 11 0.0004
712 HEPATIC CIRRHOSIS 8 0.0004
713 BLINDNESS UNILATERAL 6 0.0004
714 EYE PAIN 24 0.0004
715 RASH GENERALISED 11 0.0004
716 COVID-19 PNEUMONIA 5 0.0004
717 THROAT IRRITATION 19 0.0004
718 FRACTURE 8 0.0004
719 FEBRILE NEUTROPENIA 28 0.0004
720 FOOT FRACTURE 8 0.0004
721 PYREXIA 146 0.0004
722 NEUROLEPTIC MALIGNANT SYNDROME 5 0.0004
723 BRONCHITIS 31 0.0004
724 SKIN CANCER 9 0.0004
725 SOMNOLENCE 84 0.0004
726 PRURITUS GENERALISED 9 0.0004
727 PRODUCT USE IN UNAPPROVED INDICATION 103 0.0004
728 INCORRECT PRODUCT ADMINISTRATION DURATION 9 0.0004
729 HYPERTHYROIDISM 6 0.0004
730 LUNG NEOPLASM MALIGNANT 17 0.0004
731 MALAISE 181 0.0004
732 INCORRECT DOSE ADMINISTERED 94 0.0004
733 FEAR 11 0.0004
734 CYTOPENIA 5 0.0004
735 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
736 ASCITES 12 0.0004
737 GASTRIC DISORDER 14 0.0004
738 HYPERCALCAEMIA 5 0.0004
739 HAIR COLOUR CHANGES 5 0.0004
740 INJURY 28 0.0004
741 HYPOAESTHESIA ORAL 6 0.0004
742 BLOOD COUNT ABNORMAL 6 0.0004
743 VISUAL IMPAIRMENT 49 0.0004
744 FEELING COLD 11 0.0004
745 DRUG DISPENSING ERROR 6 0.0004
746 SURGERY 23 0.0004
747 THIRST 7 0.0004
748 VIRAL INFECTION 13 0.0004
749 JOINT SWELLING 47 0.0004
750 MUSCULOSKELETAL CHEST PAIN 6 0.0004
751 INFLUENZA 43 0.0004
752 ANGIOEDEMA 17 0.0004
753 ACCIDENTAL OVERDOSE 14 0.0004
754 ECZEMA 20 0.0004
755 THERAPEUTIC RESPONSE UNEXPECTED 17 0.0004
756 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 68 0.0004
757 OBESITY 6 0.0004
758 DYSPHONIA 22 0.0004
759 BONE PAIN 22 0.0004
760 INTENTIONAL OVERDOSE 24 0.0004
761 HEADACHE 234 0.0004
762 MUSCLE SPASMS 68 0.0004
763 ABDOMINAL PAIN 86 0.0004
764 COLITIS 14 0.0004
765 DYSKINESIA 15 0.0004
766 BACK DISORDER 6 0.0004
767 PROTEINURIA 7 0.0004
768 OROPHARYNGEAL PAIN 34 0.0004
769 DYSPEPSIA 36 0.0004
770 STAPHYLOCOCCAL INFECTION 12 0.0004
771 OSTEONECROSIS OF JAW 9 0.0004
772 APPLICATION SITE PAIN 8 0.0004
773 STOMATITIS 22 0.0004
774 ERUCTATION 7 0.0004
775 PROCEDURAL PAIN 10 0.0004
776 DEATH 310 0.0004
777 ABDOMINAL DISTENSION 37 0.0004
778 SWELLING FACE 23 0.0004
779 ABDOMINAL DISCOMFORT 59 0.0004
780 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 25 0.0004
781 PRURITUS 135 0.0004
782 HYPOACUSIS 15 0.0003
783 NASOPHARYNGITIS 64 0.0003
784 NIGHTMARE 12 0.0003
785 PARAESTHESIA ORAL 5 0.0003
786 THERAPEUTIC RESPONSE DECREASED 21 0.0003
787 HOT FLUSH 26 0.0003
788 LOCAL SWELLING 6 0.0003
789 SKIN EXFOLIATION 29 0.0003
790 UNEVALUABLE EVENT 26 0.0003
791 MEMORY IMPAIRMENT 47 0.0003
792 NIGHT SWEATS 11 0.0003
793 COLD SWEAT 6 0.0003
794 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
795 LYMPHOCYTE COUNT DECREASED 6 0.0003
796 LYMPHADENOPATHY 12 0.0003
797 NEUROPATHY PERIPHERAL 32 0.0003
798 NAUSEA 266 0.0003
799 COMA 16 0.0003
800 IMMUNODEFICIENCY 5 0.0003
801 ABDOMINAL PAIN UPPER 69 0.0003
802 FLATULENCE 19 0.0003
803 ROAD TRAFFIC ACCIDENT 14 0.0003
804 DERMATITIS 7 0.0003
805 WITHDRAWAL SYNDROME 14 0.0003
806 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 16 0.0003
807 HEPATIC FAILURE 10 0.0003
808 CRYING 12 0.0003
809 MOOD ALTERED 9 0.0003
810 FEELING ABNORMAL 79 0.0003
811 ASTHMA 37 0.0003
812 HIP ARTHROPLASTY 5 0.0003
813 LIVER INJURY 8 0.0003
814 INFECTION 47 0.0003
815 MUSCULOSKELETAL PAIN 17 0.0003
816 EMOTIONAL DISORDER 10 0.0003
817 NASAL CONGESTION 19 0.0003
818 EXTRAPYRAMIDAL DISORDER 8 0.0003
819 SINUSITIS 33 0.0003
820 DELUSION 5 0.0003
821 MENTAL DISORDER 14 0.0003
822 PRODUCT DISPENSING ERROR 7 0.0003
823 MIDDLE INSOMNIA 6 0.0003
824 HYPOCALCAEMIA 6 0.0003
825 PAIN 194 0.0003
826 DISEASE RECURRENCE 15 0.0003
827 MUSCULOSKELETAL DISORDER 6 0.0003
828 UNDERDOSE 23 0.0003
829 COVID-19 55 0.0003
830 ABSCESS 5 0.0003
831 THROMBOCYTOPENIA 35 0.0003
832 HEPATITIS 8 0.0003
833 CHOLESTASIS 6 0.0003
834 SNEEZING 7 0.0003
835 DRUG RESISTANCE 8 0.0003
836 ERYTHEMA 64 0.0003
837 GENERAL PHYSICAL HEALTH DETERIORATION 36 0.0003
838 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 8 0.0003
839 SWELLING 29 0.0003
840 FATIGUE 241 0.0003
841 WEIGHT INCREASED 69 0.0003
842 PHARMACEUTICAL PRODUCT COMPLAINT 8 0.0003
843 DIPLOPIA 8 0.0003
844 SKIN FISSURES 6 0.0003
845 MYALGIA 52 0.0003
846 TINNITUS 14 0.0003
847 OSTEONECROSIS 10 0.0003
848 ADVERSE EVENT 28 0.0003
849 LEUKOPENIA 15 0.0003
850 ARTHRALGIA 124 0.0003
851 FACE OEDEMA 5 0.0003
852 DISEASE PROGRESSION 35 0.0003
853 LETHARGY 17 0.0003
854 RASH PRURITIC 16 0.0003
855 PULMONARY EMBOLISM 28 0.0003
856 EPILEPSY 9 0.0003
857 RASH 128 0.0003
858 PRODUCT USE ISSUE 55 0.0003
859 SKIN LESION 8 0.0003
860 DIABETIC KETOACIDOSIS 7 0.0003
861 ILLNESS 30 0.0003
862 PARANOIA 5 0.0003
863 NEURALGIA 7 0.0003
864 SPEECH DISORDER 15 0.0003
865 INCORRECT DRUG ADMINISTRATION DURATION 8 0.0003
866 DRY MOUTH 23 0.0003
867 AGEUSIA 7 0.0003
868 INTENTIONAL DOSE OMISSION 8 0.0003
869 HYPERSOMNIA 8 0.0003
870 DISCOMFORT 17 0.0003
871 DRUG INEFFECTIVE 367 0.0003
872 GASTROENTERITIS VIRAL 5 0.0003
873 URTICARIA 46 0.0003
874 PANIC ATTACK 10 0.0003
875 OFF LABEL USE 239 0.0003
876 LABORATORY TEST ABNORMAL 8 0.0003
877 BURNING SENSATION 19 0.0003
878 BLOOD GLUCOSE ABNORMAL 5 0.0003
879 FUNGAL INFECTION 9 0.0003
880 NEOPLASM MALIGNANT 18 0.0003
881 GLOSSODYNIA 6 0.0003
882 EYE PRURITUS 9 0.0003
883 ANGER 9 0.0003
884 FLUSHING 27 0.0003
885 PRODUCT QUALITY ISSUE 36 0.0003
886 LACRIMATION INCREASED 8 0.0003
887 PRODUCT STORAGE ERROR 23 0.0003
888 INTENTIONAL PRODUCT USE ISSUE 23 0.0003
889 VERTIGO 16 0.0003
890 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 53 0.0003
891 EYE IRRITATION 15 0.0003
892 DRY EYE 13 0.0003
893 PAIN OF SKIN 7 0.0003
894 COGNITIVE DISORDER 12 0.0003
895 TARDIVE DYSKINESIA 7 0.0002
896 PARAESTHESIA 39 0.0002
897 THERAPEUTIC PRODUCT EFFECT DECREASED 11 0.0002
898 GASTROINTESTINAL DISORDER 22 0.0002
899 ENCEPHALOPATHY 6 0.0002
900 EYE SWELLING 9 0.0002
901 VISUAL ACUITY REDUCED 8 0.0002
902 LIVER FUNCTION TEST ABNORMAL 7 0.0002
903 INTENTIONAL PRODUCT MISUSE 21 0.0002
904 DRY SKIN 32 0.0002
905 MUSCULOSKELETAL STIFFNESS 21 0.0002
906 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 13 0.0002
907 MOBILITY DECREASED 17 0.0002
908 PROSTATE CANCER 19 0.0002
909 OESOPHAGEAL CARCINOMA 7 0.0002
910 IMPAIRED WORK ABILITY 5 0.0002
911 ARTHROPATHY 13 0.0002
912 ERECTILE DYSFUNCTION 6 0.0002
913 INCORRECT DOSE ADMINISTERED BY DEVICE 6 0.0002
914 RASH MACULAR 8 0.0002
915 FEELING HOT 14 0.0002
916 INJECTION SITE RASH 7 0.0002
917 PANCREATITIS 12 0.0002
918 TOXICITY TO VARIOUS AGENTS 38 0.0002
919 NERVOUS SYSTEM DISORDER 7 0.0002
920 PRODUCT ADHESION ISSUE 8 0.0002
921 EMOTIONAL DISTRESS 27 0.0002
922 DRUG EFFECT DECREASED 12 0.0002
923 DRUG EFFECT INCOMPLETE 8 0.0002
924 WRONG TECHNIQUE IN DRUG USAGE PROCESS 8 0.0002
925 HEPATIC ENZYME INCREASED 15 0.0002
926 LOWER RESPIRATORY TRACT INFECTION 10 0.0002
927 HYPERSENSITIVITY 40 0.0002
928 DYSGEUSIA 16 0.0002
929 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
930 PRODUCT DOSE OMISSION 14 0.0002
931 SUICIDE ATTEMPT 13 0.0002
932 DRUG DOSE OMISSION 35 0.0002
933 HEPATIC CANCER 5 0.0002
934 PANCREATIC CARCINOMA 6 0.0002
935 PSYCHOTIC DISORDER 6 0.0002
936 INJECTION SITE BRUISING 16 0.0002
937 AGGRESSION 10 0.0002
938 MEDICATION ERROR 11 0.0002
939 ABDOMINAL PAIN LOWER 5 0.0002
940 ILL-DEFINED DISORDER 12 0.0002
941 PSORIATIC ARTHROPATHY 8 0.0002
942 INFUSION RELATED REACTION 13 0.0002
943 MYELOSUPPRESSION 7 0.0002
944 SWOLLEN TONGUE 6 0.0002
945 DEAFNESS 5 0.0002
946 MUCOSAL INFLAMMATION 5 0.0002
947 DEVICE ISSUE 17 0.0002
948 INJECTION SITE PAIN 58 0.0002
949 EAR INFECTION 5 0.0002
950 CHILLS 22 0.0002
951 FREQUENT BOWEL MOVEMENTS 5 0.0002
952 RHEUMATOID ARTHRITIS 21 0.0002
953 DEVICE LEAKAGE 8 0.0002
954 ACCIDENTAL EXPOSURE TO PRODUCT 19 0.0002
955 SEIZURE 21 0.0002
956 ANAPHYLACTIC REACTION 10 0.0002
957 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
958 LIP SWELLING 6 0.0002
959 ADVERSE DRUG REACTION 16 0.0002
960 NEOPLASM PROGRESSION 6 0.0002
961 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
962 INFLUENZA LIKE ILLNESS 14 0.0002
963 SLEEP DISORDER 12 0.0002
964 NEUTROPENIA 23 0.0002
965 ALOPECIA 33 0.0002
966 INJECTION SITE MASS 6 0.0002
967 MOOD SWINGS 5 0.0002
968 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
969 INJECTION SITE ERYTHEMA 19 0.0002
970 BLADDER CANCER 9 0.0002
971 EXPIRED PRODUCT ADMINISTERED 5 0.0002
972 IRRITABILITY 9 0.0001
973 OVERDOSE 32 0.0001
974 OCULAR HYPERAEMIA 7 0.0001
975 MALIGNANT NEOPLASM PROGRESSION 15 0.0001
976 TREATMENT FAILURE 12 0.0001
977 INJECTION SITE SWELLING 11 0.0001
978 DRUG INTOLERANCE 13 0.0001
979 COMPLETED SUICIDE 11 0.0001
980 MULTIPLE SCLEROSIS RELAPSE 9 0.0001
981 DISTURBANCE IN ATTENTION 7 0.0001
982 DEVICE MALFUNCTION 9 0.0001
983 DRUG WITHDRAWAL SYNDROME 11 0.0001
984 PSORIASIS 16 0.0001
985 EXPOSURE DURING PREGNANCY 7 0.0001
986 SKIN BURNING SENSATION 8 0.0001
987 DEVICE DIFFICULT TO USE 7 0.0001
988 MIGRAINE 10 0.0001
989 INJECTION SITE PRURITUS 7 0.0001
990 PRODUCT SUBSTITUTION ISSUE 6 0.0001
991 DRUG DOSE OMISSION BY DEVICE 8 0.0001
992 INJECTION SITE HAEMORRHAGE 8 0.0001
993 BREAST CANCER 5 0.0001